Matthews, D.J. et al. Discovery of PI3K delta inhibitors for the treatment of inflammatory and autoimmune disease. 2012 New York Academy of Sciences Meeting Poster.
“Importantly, PWT143 inhibits basophil activation (as measured by surface CD63 expression in a whole blood assay) with subnanomolar potency in response to anti-IgE stimulation but not in response to fMLP stimulation, suggesting a differential effect on autoimmune compared to bacterial antigen-mediated immune cell activation.”
Welcome to the website of Buhlmann Diagnostics Corp. By continuing your visit to our website you will be deemed to have accepted the Terms of Use. If you don't wish to accept the Terms of Use please discontinue your visit. OK